SS
KURA icon

SBI Securities’s Kura Oncology KURA Stock Holding History

SBI Securities’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.58K Sell
326
-8
-2% -$75 ﹤0.01% 2332
2026
Q1 		$2.71K Buy
334
+3
+0.9% +$26 ﹤0.01% 2305
2025
Q4 		$3.44K Buy
331
+300
+968% +$3.15K ﹤0.01% 2183
2025
Q3 		$274 Buy
31
+2
+7% +$14 ﹤0.01% 3214
2025
Q2 		$167 Hold
29
– – ﹤0.01% 3374
2025
Q1 		$191 Hold
29
– – ﹤0.01% 3238
2024
Q4 		$253 Buy
+29
New +$417 ﹤0.01% 3159

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

SBI Securities's KURA Position: Q2 2026 in Review

SBI Securities reduced its Kura Oncology (KURA) stake by 2.4% in Q2 2026, selling an estimated $75 and leaving 326 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

SBI Securities first reported a position in KURA in Q4 2024 and has held it in 7 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • SBI Securities held 326 shares of Kura Oncology worth $3.58K as of Q2 2026.
  • SBI Securities sold 8 Kura Oncology shares in Q2 2026, an estimated $75.
  • Kura Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2332 holding.
  • SBI Securities first reported a position in Kura Oncology in Q4 2024 and has held it in 7 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.